Skip to main content

Remote Job Finders (RJF)

GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena

GSK secures rights to Boston Pharmaceuticals’ efimosfermin alfa, which the pharma plans to develop for fatty liver diseases such as metabolic dysfunction-associated steatohepatitis and alcohol-related liver disease.

Roche Continues US Investments With $550M Diagnostics Push in Lilly’s Backyard

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems. The news comes on the heels of an announced $700 million investment in North Carolina.
Scroll to top